Showing results (131-140 of 148) with videos related to
Sort By:
Pageof 15
European Journal of Medicinal Chemistry|June 12, 2021
Benzofuranyl-2-imidazoles as imidazoline I2 receptor ligands for Alzheimer's diseaseSergio Rodriguez-Arévalo, Andrea Bagán, Christian Griñán-Ferré, et al.Scientific Data|July 13, 2022
Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effortAndrea Zaliani, Laura Vangeel, Jeanette Reinshagen, et al.Microorganisms|March 29, 2023
Identification of Z-Tyr-Ala-CHN2, a Cathepsin L Inhibitor with Broad-Spectrum Cell-Specific Activity against Coronaviruses, including SARS-CoV-2Jordi Doijen, Koen Temmerman, Christel Van den Eynde, et al.Signal Transduction and Targeted Therapy|April 20, 2025
Subnanomolar MAS-related G protein-coupled receptor-X2/B2 antagonists with efficacy in human mast cells and disease modelsGhazl Al Hamwi, Mohamad Wessam Alnouri, Sven Verdonck, et al.Antiviral Research|April 7, 2022
HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effectCaroline S Foo, Rana Abdelnabi, Suzanne J F Kaptein, et al.Journal of Medicinal Chemistry|March 10, 2020
Bicyclic α-Iminophosphonates as High Affinity Imidazoline I2 Receptor Ligands for Alzheimer's DiseaseSònia Abás, Sergio Rodríguez-Arévalo, Andrea Bagán, et al.Journal of the American Chemical Society|February 10, 2022
Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against CoronavirusesAndreas Luttens, Hjalmar Gullberg, Eldar Abdurakhmanov, et al.Biorxiv : the Preprint Server for Biology|April 25, 2024
PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2Marwah Karim, Manjari Mishra, Chieh-Wen Lo, et al.Molecules (Basel, Switzerland)|February 15, 2022
Synthesis, Structure-Activity Relationships, and Antiviral Profiling of 1-Heteroaryl-2-Alkoxyphenyl Analogs as Inhibitors of SARS-CoV-2 ReplicationDorothée Bardiot, Laura Vangeel, Mohamed Koukni, et al.ACS Pharmacology & Translational Science|March 15, 2022
Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing ScreenMaria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, et al.Pageof 15